These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26374452)

  • 41. Tissue Expression and Prognostic Role of CXCL12 and CXCR4 in High-grade Serous Ovarian Carcinoma.
    Lim H; Kim SI; Kim EN; Lee M; Lee C; Kim JW; Chung HH
    Anticancer Res; 2023 Jul; 43(7):3331-3340. PubMed ID: 37351997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
    Xie X; Clausen OP; Boysen M
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
    Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
    BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.
    Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M
    Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCR4: A New Player in an Old Scene?
    Knopf A; Fritsche MK; Li Y
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):34-42. PubMed ID: 28231592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
    Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
    Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
    Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
    Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
    Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
    Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
    J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The dilemma of follow-up in head and neck cancer patients.
    Haas I; Hauser U; Ganzer U
    Eur Arch Otorhinolaryngol; 2001 May; 258(4):177-83. PubMed ID: 11407449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
    Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
    Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
    Bockmühl U; Küchler I; Petersen I
    HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.